Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 519, Issue 1-2, Pages 287-303Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2017.01.037
Keywords
Polymersome; Theranostics; Cancer; Diagnostics; Copolymer
Categories
Funding
- Mashhad University of Medical Sciences
Ask authors/readers for more resources
Polymersomes are polymeric vesicles that have numerous advantages for theranostics, the integrated approach of therapeutics and diagnostics. Polymersomes possess core-shell structures which encapsulate hydrophilic molecules in the aqueous compartment and hydrophobic molecules in the bilayer of the vesicles. Polymersomes are made of different amphiphilic block copolymers. Thus, in the process of designing polymersomes, a variety of amphiphilic block copolymers with different molecular weights are used to develop intelligent or sustained released formulations and to modify the stability of the system and bilayer thickness or to functionalize the particle with targeting moieties to improve the delivery efficiency. In addition, biocompatible and/or biodegradable polymersomes are diverse in size and charge which show low toxicity in vivo. Polymersomes are increasingly being used as platforms for simultaneous drug delivery and imaging and are therefore becoming popular theranostic nanoparticles. This review focuses on the methods of nanoparticle formation when polymersomes for theranostic nanomedicine are engineered. We highlight recent examples of polymersome theranostic systems from literature and their potential for use in the clinic, particularly biodegradable or biocompatible-based NPs. (C) 2017 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available